403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Europe Equine Healthcare Market Predicted To Grow Expeditiously: To Surpass US$ 1,959.48 Million CAGR 6.3% By 2032
(MENAFN- EIN Presswire)
The market in Europe equine healthcare is on a growth trajectory. The market, valued at USD 1,128.78 million in 2023, is poised to reach USD 1,959.48 million by 2032. It is anticipated to register a CAGR of 6.3% from 2024 to 2032.
Market Introduction:
Besides appropriately feeding and exercising the horse, other facets of general care are required to sustain the health of the horse throughout his or her life. These involve accustomed veterinary care for vaccination, parasite regulation, dental care, conditioning and hoof care, and safeguarding from the elements. Grown-up horses should have an entire veterinary inspection at least once a year.
Download Free Sample PDF Copy of the Report:
/request-for-sample
Normal indications of illness involve the absence of appetite, diarrhea, coughing, sneezing, or dispensation from the eyes or nose. Illness can also result in a loss of hair and itchy regions on the skin. Issues with the musculoskeletal system are frequently observed as a disability, unwillingness to move, or head bobbing. The growth of equestrian ventures in Europe impacts the Europe equine healthcare market demand favourably.
Key Report Highlights:
.The Europe equine healthcare market size was valued at USD 1,128.78 million in 2023 and is projected to grow to USD 1,959.48 million by 2032.
.The aggregate of horses in Europe surges as equestrian ventures, including enjoyable riding, fierce sports, and breeding, which fuel the need for equine healthcare in Europe.
.The market segmentation is primarily based on product, indication, activity, distribution channel, and country.
.The study provides market insights into Germany, France, the UK, Italy, Spain, Netherlands, Russia, and the rest of Europe.
Competitive Landscape:
The Europe equine healthcare market is portrayed by competitiveness.
The top market participants are
.Zoetis Services LLC
.Boehringer Ingelheim International GmbH
.Arthrex Inc.
.Dechra
.Ceva Sante Animale
.Merck & Co., Inc.
.Heska Corporation
.Hallmarq Veterinary Imaging
.ESAOTE SPA
.Vetoquinol S.A.
.IDEXX Laboratories, Inc.
.Elanco
.Covetrus Inc.
.Cargill
.Biosig Instruments Inc.
Market contenders are also assuring an assortment of tactical ventures to augment their global footprint.
Here are some of the major market developments:
.In March 2023, Zoetis, a prominent player in animal health, declared the augmentation of its universal diagnostic platform, Vetscan Imagyst, to involve two contemporary applications, one for AI dermatology and the other for AI equine FEC inspection.
.In August 2021, Dechra declared the instigation of contemporary antibiotic oral powder Equibactin to cure horses from bacterial conformation.
Request for a Discount on this Report Before Purchase:
/request-for-discount-pricing
Growth Drivers and Opportunities:
Prevalence of Key Players: The existence of critical players in Europe is anticipated to generate notable possibilities for the market in the course of the forecast period, fueling the Europe equine healthcare market growth.
Implementation of Stringent Animal Welfare Directives: European governments frequently execute and administer strict animal welfare directives. These regulations accept structured veterinary assessment, vaccinations, and prohibitive care to guarantee the health and comfort of horses.
Growing Aggregate of Start-ups: The approach of contemporary players in the market generates an aggressive ambiance amidst contemporary and prevailing market contenders. The contesting causes enhanced and progressive services, superlative costing, and additional alternatives for horse owners.
Regional Analysis:
The UK is anticipated to witness a significant CAGR from 2024 to 2032. The country's robust growth is due to the escalating significance of entertaining riding and the growing aggregate of leisure horses.
Germany accounted for the largest share of the Europe equine healthcare market in 2023. This is primarily because of its entrenched equestrian industry and strong healthcare framework.
Inquire more about this Report Before Purchase:
/inquire-before-buying
Segmental Overview:
By Product Outlook:
.Vaccines
.Pharmaceuticals
oParasiticides
oAnti-infectives
oAnti-inflammatory & Analgesics
oOther Pharmaceuticals
.Medicinal Feed Additives
.Orthobiologics
.Diagnostics
oDiagnostic Test Kits
oDiagnostic Equipment
oSoftware
.Practice Management Software
oImaging Software
oTelehealth Software
oOther Software
.Other
By Indication Outlook:
.Musculoskeletal Disorders
.Parasitic Infections
.Equine Herpes Virus
.Equine Viral Arteritis (EVA)
.Equine Influenza
.West Nile Virus
.Tetanus
.Other
By Activity Outlook:
.Sports/Racing
.Recreation
.Other
By Distribution Channel Outlook:
.Veterinary Hospitals & Clinics
.E-commerce
.Equestrian Facilities
.Other
By Country Outlook
.Germany
.UK
.France
.Italy
.Spain
.Switzerland
.Sweden
.Netherland
.Russia
.Rest of Europe
Browse More Research Reports:
Protein A, G and L Resins Market:
T4 DNA Ligase Market:
Cell & Gene Therapy Bioanalytical Testing Services Market:
Plasma Protease C1-inhibitor Market:
Surgical Planning Software Market:
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
Europe Equine Healthcare Market
The escalating existence of equine illnesses in Europe is driving the demand for Europe equine healthcare market.
Elevated illness existence brings on a robust concentration on prohibitive care involving vaccinations, parasite regulation, and biosecurity measures” - Polaris market ResearchNEW YORK CITY, NY, UNITED STATES, October 31, 2024 /EINPresswire / -- The Europe equine healthcare market report assesses the competitive scenario of the market, examining all the established players and new market entrants.The market in Europe equine healthcare is on a growth trajectory. The market, valued at USD 1,128.78 million in 2023, is poised to reach USD 1,959.48 million by 2032. It is anticipated to register a CAGR of 6.3% from 2024 to 2032.
Market Introduction:
Besides appropriately feeding and exercising the horse, other facets of general care are required to sustain the health of the horse throughout his or her life. These involve accustomed veterinary care for vaccination, parasite regulation, dental care, conditioning and hoof care, and safeguarding from the elements. Grown-up horses should have an entire veterinary inspection at least once a year.
Download Free Sample PDF Copy of the Report:
/request-for-sample
Normal indications of illness involve the absence of appetite, diarrhea, coughing, sneezing, or dispensation from the eyes or nose. Illness can also result in a loss of hair and itchy regions on the skin. Issues with the musculoskeletal system are frequently observed as a disability, unwillingness to move, or head bobbing. The growth of equestrian ventures in Europe impacts the Europe equine healthcare market demand favourably.
Key Report Highlights:
.The Europe equine healthcare market size was valued at USD 1,128.78 million in 2023 and is projected to grow to USD 1,959.48 million by 2032.
.The aggregate of horses in Europe surges as equestrian ventures, including enjoyable riding, fierce sports, and breeding, which fuel the need for equine healthcare in Europe.
.The market segmentation is primarily based on product, indication, activity, distribution channel, and country.
.The study provides market insights into Germany, France, the UK, Italy, Spain, Netherlands, Russia, and the rest of Europe.
Competitive Landscape:
The Europe equine healthcare market is portrayed by competitiveness.
The top market participants are
.Zoetis Services LLC
.Boehringer Ingelheim International GmbH
.Arthrex Inc.
.Dechra
.Ceva Sante Animale
.Merck & Co., Inc.
.Heska Corporation
.Hallmarq Veterinary Imaging
.ESAOTE SPA
.Vetoquinol S.A.
.IDEXX Laboratories, Inc.
.Elanco
.Covetrus Inc.
.Cargill
.Biosig Instruments Inc.
Market contenders are also assuring an assortment of tactical ventures to augment their global footprint.
Here are some of the major market developments:
.In March 2023, Zoetis, a prominent player in animal health, declared the augmentation of its universal diagnostic platform, Vetscan Imagyst, to involve two contemporary applications, one for AI dermatology and the other for AI equine FEC inspection.
.In August 2021, Dechra declared the instigation of contemporary antibiotic oral powder Equibactin to cure horses from bacterial conformation.
Request for a Discount on this Report Before Purchase:
/request-for-discount-pricing
Growth Drivers and Opportunities:
Prevalence of Key Players: The existence of critical players in Europe is anticipated to generate notable possibilities for the market in the course of the forecast period, fueling the Europe equine healthcare market growth.
Implementation of Stringent Animal Welfare Directives: European governments frequently execute and administer strict animal welfare directives. These regulations accept structured veterinary assessment, vaccinations, and prohibitive care to guarantee the health and comfort of horses.
Growing Aggregate of Start-ups: The approach of contemporary players in the market generates an aggressive ambiance amidst contemporary and prevailing market contenders. The contesting causes enhanced and progressive services, superlative costing, and additional alternatives for horse owners.
Regional Analysis:
The UK is anticipated to witness a significant CAGR from 2024 to 2032. The country's robust growth is due to the escalating significance of entertaining riding and the growing aggregate of leisure horses.
Germany accounted for the largest share of the Europe equine healthcare market in 2023. This is primarily because of its entrenched equestrian industry and strong healthcare framework.
Inquire more about this Report Before Purchase:
/inquire-before-buying
Segmental Overview:
By Product Outlook:
.Vaccines
.Pharmaceuticals
oParasiticides
oAnti-infectives
oAnti-inflammatory & Analgesics
oOther Pharmaceuticals
.Medicinal Feed Additives
.Orthobiologics
.Diagnostics
oDiagnostic Test Kits
oDiagnostic Equipment
oSoftware
.Practice Management Software
oImaging Software
oTelehealth Software
oOther Software
.Other
By Indication Outlook:
.Musculoskeletal Disorders
.Parasitic Infections
.Equine Herpes Virus
.Equine Viral Arteritis (EVA)
.Equine Influenza
.West Nile Virus
.Tetanus
.Other
By Activity Outlook:
.Sports/Racing
.Recreation
.Other
By Distribution Channel Outlook:
.Veterinary Hospitals & Clinics
.E-commerce
.Equestrian Facilities
.Other
By Country Outlook
.Germany
.UK
.France
.Italy
.Spain
.Switzerland
.Sweden
.Netherland
.Russia
.Rest of Europe
Browse More Research Reports:
Protein A, G and L Resins Market:
T4 DNA Ligase Market:
Cell & Gene Therapy Bioanalytical Testing Services Market:
Plasma Protease C1-inhibitor Market:
Surgical Planning Software Market:
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
Likhil G
Polaris Market Research and Consulting
+ + 1 929-297-9727
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment